What do Amazon and Netflix have in common with pharma's HCP engagement model? More than you think

20 May 2021
amazon_big

AJ Ploszay, vice president of digital strategy, IQVIA, provides an Expert View on how the precedent for consumer buying set by companies like Amazon, further accelerated by the digital buying trends driven by COVID-19, are influencing a similar shift in the commercial pharma space.

Amazon has redefined the buyer experience of virtually all consumers. A single source is expected to provide any product imaginable to any doorstep, within days, with the click of a button.

Netflix has equally changed the entertainment industry by providing on demand access to the latest content, making recommendations for new shows that may be of interest based on prior activity. What do these trends have to do with the pharmaceutical industry? It is all connected. Health care providers (HCPs), who are consumers in their own right, have come to expect the same contextually rich, personalized customer experience they get in their personal lives from their pharmaceutical partner – and they want it easily accessible on their phones and computers.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Pharmaceutical